Very low levels of bad cholesterol well-tolerated in heart disease patients

Heart disease patients taking PCSK9 inhibitors to achieve very low levels of cholesterol do not experience an increase in adverse events, including memory impairment or nervous system disorders, but may have an increased risk of cataracts, according to a study.

Leave a Reply

Your email address will not be published. Required fields are marked *